Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer

• Prif Awduron: Chueh-Yi Huang (Awdur), Yuh-Cheng Yang (Awdur), Kung-Liahng Wang (Awdur), Tze-Chien Chen (Awdur), Jen-Ruei Chen (Awdur), Chia-Sui Weng (Awdur), Hung-Ju Chien (Awdur), Chih-Long Chang (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2016-06-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Objective: To dissect the correlated hematologic markers that reflect the clinical outcome or treatment response in patients receiving dose-dense chemotherapy with a combination of platinum (cisplatin or carboplatin) and paclitaxel. Materials and Methods: From 2009 to 2014, we enrolled 55 ovarian ca...